Analytical Data
-
Gene name
CREG1/CREG
- Application
-
Alternative Names
rMuProtein CREG1/CREG, His; CREG1; cellular repressor of E1A-stimulated genes; cellular repressor of E1A-stimulated genes 1CREG; protein CREG1
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
O88668
-
Expression Region
Ser75~Gln220
-
Molecular Weight
20kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CREG1, also known as CREG (Cellular Regulator of EGF), is a secreted protein that has garnered attention due to its role in various physiological and pathological processes. Initially identified for its involvement in cell proliferation and differentiation, CREG1 has since been implicated in tissue repair, inflammation, and cancer progression. Its expression is regulated by several growth factors and cytokines, suggesting its role as a modulator in cellular responses. The protein interacts with key pathways such as the EGF receptor signaling, influencing cellular behaviors critical for development and response to injury. Recent studies have highlighted the potential of CREG1 as a therapeutic target due to its dual role in promoting tissue regeneration while also participating in tumorigenesis. Moreover, research into the recombinant production of CREG1 aims to harness its biological functions for clinical applications, such as enhancing wound healing or developing anti-cancer therapies. As understanding of CREG1’s molecular mechanisms deepens, it holds promise for advancing regenerative medicine and oncology, making it a significant focus in current biomedical research.
